Lassa virus (LASV) is the pathogen that causes Lassa hemorrhagic fever, a disease endemic to West Africa, which causes approximately 5,000 deaths each year. At the CSSB Centre for Structural Systems ...

While combing through the human genome in 2007, computational geneticist Pardis Sabeti made a discovery that would transform her research career. As a then-postdoctoral fellow at the Broad Institute ...

Researchers at the University of Texas Medical Branch have achieved success with a new vaccine developed to fight Lassa Virus, a pathogen that causes Lassa fever. Lassa fever is lethal in humans and ...

The clinical trial of a Lassa fever candidate vaccine has begun enrolling participants at the University of Maryland School of Medicine, Baltimore. Lassa virus (a member of the Arenavirus family) ...

ALAMEDA, Calif., July 29, 2026 /PRNewswire/ -- Alveo Technologies, Inc. (Alveo), a leader in portable molecular sensing solutions, today announced a strategic partnership with The University of Texas ...

The Oxford Vaccine Group has vaccinated the first volunteer in a first-in-human trial of a Lassa vaccine. This Coalition for Epidemic Preparedness Innovations (CEPI)-funded trial is being conducted in ...

Please provide your email address to receive an email when new articles are posted on . The candidate vaccine is based on a modified, weakened rabies virus vaccine. There are no approved vaccines or ...

A new study led by researchers at the Institute for Global Health and Infectious Diseases at the University of North Carolina School of Medicine in Chapel Hill shows an urgent need for improved ...

NEW YORK--(BUSINESS WIRE)--IAVI, a nonprofit scientific research organization, announces that volunteers at the PREVAIL clinical trial site at Redemption Hospital (RH 1) in Monrovia, Liberia, have ...

A case of Lassa fever has been reported in Paris, France, sparking lurid warnings about the “horrific Ebola-like bug”. As the name suggests, Lassa fever causes a high temperature, but also weakness, ...

Researchers report the results of the first ever genome-wide association study (GWAS) of a biosafety level 4 (BSL-4) virus. The team found two key human genetic factors that could help explain why ...